According to literature reports, the interaction of Siglec-15 with its ligands CD44, MAG, and sialyl-Tn mediates immune escape in the tumor microenvironment, thus affecting the development of tumors [10,11,12,13,14,15]. Here, CD44 is linked to neoplasm.